Sponsor
Sally E. Wenzel MD
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Sally E. Wenzel MD appears in 5 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
5 shownMeasuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe AsthmaNCT04743791 · lead sponsor · 2022-10-17
RECRUITINGImplications and Stability of Clinical and Molecular Phenotypes of Severe AsthmaNCT01748175 · lead sponsor · 2013-01-01
COMPLETEDElectrophilic Fatty Acid Derivatives in AsthmaNCT01733485 · lead sponsor · 2011-10-01
COMPLETEDAnti-Inflammatory Lipid Mediators in AsthmaNCT03680976 · lead sponsor
WITHDRAWNDupilumab Compassionate Use StudyNCT03020810 · lead sponsor
APPROVED_FOR_MARKETINGSponsor roles
lead sponsor5
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.